Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T14:42:23.752Z.
Calculation as of: 2026-10-06T14:42:23.752Z.
Quote observation: 2026-10-06T14:40:29.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 97f82c903e8e6ec217280dce7f3fe4a68629f44b5a27270464b7740b55d93be6
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Opus Genetics, Inc.
Market Cap
$347.70M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$349.23M
Operating Cash Flow Yield
N/A
TTM Avg
3.39%
3Y Avg
3.76%
5Y Avg
5.04%
Market Cap
$352.93M
Operating Cash Flow Yield
N/A
TTM Avg
15.24%
3Y Avg
15.24%
5Y Avg
15.24%
Market Cap
$342.13M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$354.19M
Operating Cash Flow Yield
49.15%
TTM Avg
54.62%
3Y Avg
24.22%
5Y Avg
23.43%
Market Cap
$355.99M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$332.73M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$334.29M
Operating Cash Flow Yield
N/A
TTM Avg
1.16%
3Y Avg
1.16%
5Y Avg
1.16%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Opus Genetics, Inc. (IRD) | $347.70M | N/A | N/A | N/A | N/A |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $349.23M | N/A | 3.39% | 3.76% | 5.04% |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $352.93M | N/A | 15.24% | 15.24% | 15.24% |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $342.13M | N/A | N/A | N/A | N/A |
| Embecta Corp. (EMBC)vs › | $354.19M | 49.15% | 54.62% | 24.22% | 23.43% |
| Ocugen, Inc. (OCGN)vs › | $354.37M | N/A | N/A | N/A | N/A |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $355.99M | N/A | N/A | N/A | N/A |
| ClearPoint Neuro, Inc. (CLPT)vs › | $332.73M | N/A | N/A | N/A | N/A |
| Agenus Inc. (AGEN)vs › | $334.29M | N/A | 1.16% | 1.16% | 1.16% |
| Canopy Growth Corporation (CGC)vs › | $370.48M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
